Mogy Joel R Investment Counsel’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $910K | Hold |
15,795
| – | – | 0.05% | 70 |
|
|
2026
Q1 | $958K | Sell |
15,795
-3,150
| -17% | -$184K | 0.06% | 64 |
|
|
2025
Q4 | $1.02M | Hold |
18,945
| – | – | 0.06% | 64 |
|
|
2025
Q3 | $854K | Hold |
18,945
| – | – | 0.05% | 69 |
|
|
2025
Q2 | $877K | Hold |
18,945
| – | – | 0.05% | 66 |
|
|
2025
Q1 | $1.16M | Sell |
18,945
-215
| -1% | -$12.5K | 0.07% | 59 |
|
|
2024
Q4 | $1.08M | Hold |
19,160
| – | – | 0.06% | 65 |
|
|
2024
Q3 | $991K | Sell |
19,160
-1,000
| -5% | -$46.9K | 0.06% | 69 |
|
|
2024
Q2 | $837K | Sell |
20,160
-1
| -0% | -$45 | 0.05% | 70 |
|
|
2024
Q1 | $1.09M | Sell |
20,161
-749
| -4% | -$38.2K | 0.07% | 66 |
|
|
2023
Q4 | $1.07M | Hold |
20,910
| – | – | 0.08% | 65 |
|
|
2023
Q3 | $1.21M | Sell |
20,910
-10,000
| -32% | -$613K | 0.1% | 61 |
|
|
2023
Q2 | $1.98M | Sell |
30,910
-300
| -1% | -$20.1K | 0.16% | 58 |
|
|
2023
Q1 | $2.16M | Buy |
31,210
+1
| +0% | +$71 | 0.19% | 50 |
|
|
2022
Q4 | $2.25M | Hold |
31,209
| – | – | 0.22% | 48 |
|
|
2022
Q3 | $2.22M | Hold |
31,209
| – | – | 0.23% | 51 |
|
|
2022
Q2 | $2.4M | Buy |
31,209
+314
| +1% | +$23.9K | 0.24% | 50 |
|
|
2022
Q1 | $2.26M | Hold |
30,895
| – | – | 0.18% | 52 |
|
|
2021
Q4 | $1.93M | Hold |
30,895
| – | – | 0.14% | 56 |
|
|
2021
Q3 | $1.83M | Hold |
30,895
| – | – | 0.15% | 57 |
|
|
2021
Q2 | $2.06M | Hold |
30,895
| – | – | 0.17% | 56 |
|
|
2021
Q1 | $1.95M | Hold |
30,895
| – | – | 0.19% | 55 |
|
|
2020
Q4 | $1.92M | Hold |
30,895
| – | – | 0.19% | 55 |
|
|
2020
Q3 | $1.86M | Hold |
30,895
| – | – | 0.2% | 53 |
|
|
2020
Q2 | $1.82M | Hold |
30,895
| – | – | 0.22% | 51 |
|
|
2020
Q1 | $1.72M | Hold |
30,895
| – | – | 0.24% | 53 |
|
|
2019
Q4 | $1.98M | Hold |
30,895
| – | – | 0.24% | 57 |
|
|
2019
Q3 | $1.57M | Hold |
30,895
| – | – | 0.2% | 65 |
|
|
2019
Q2 | $1.4M | Sell |
30,895
-200
| -0.6% | -$9.32K | 0.18% | 69 |
|
|
2019
Q1 | $1.48M | Hold |
31,095
| – | – | 0.2% | 65 |
|
|
2018
Q4 | $1.62M | Hold |
31,095
| – | – | 0.25% | 60 |
|
|
2018
Q3 | $1.93M | Hold |
31,095
| – | – | 0.26% | 61 |
|
|
2018
Q2 | $1.72M | Hold |
31,095
| – | – | 0.25% | 62 |
|
|
2018
Q1 | $1.97M | Sell |
31,095
-600
| -2% | -$38.6K | 0.31% | 58 |
|
|
2017
Q4 | $1.94M | Hold |
31,695
| – | – | 0.3% | 56 |
|
|
2017
Q3 | $2.02M | Hold |
31,695
| – | – | 0.34% | 58 |
|
|
2017
Q2 | $1.77M | Sell |
31,695
-402
| -1% | -$21.9K | 0.3% | 59 |
|
|
2017
Q1 | $1.75M | Sell |
32,097
-500
| -2% | -$27.4K | 0.3% | 61 |
|
|
2016
Q4 | $1.91M | Hold |
32,597
| – | – | 0.35% | 60 |
|
|
2016
Q3 | $1.76M | Hold |
32,597
| – | – | 0.32% | 65 |
|
|
2016
Q2 | $2.4M | Hold |
32,597
| – | – | 0.44% | 56 |
|
|
2016
Q1 | $2.08M | Buy |
32,597
+29,338
| +900% | +$1.85M | 0.39% | 60 |
|
|
2015
Q4 | $2.24K | Sell |
3,259
-25,838
| -89% | -$1.71M | 0.42% | 54 |
|
|
2015
Q3 | $1.72M | Hold |
29,097
| – | – | 0.34% | 61 |
|
|
2015
Q2 | $1.94M | Hold |
29,097
| – | – | 0.37% | 58 |
|
|
2015
Q1 | $1.88M | Hold |
29,097
| – | – | 0.35% | 63 |
|
|
2014
Q4 | $1.72M | Hold |
29,097
| – | – | 0.33% | 66 |
|
|
2014
Q3 | $1.49M | Hold |
29,097
| – | – | 0.3% | 67 |
|
|
2014
Q2 | $1.41M | Sell |
29,097
-500
| -2% | -$24.6K | 0.28% | 70 |
|
|
2014
Q1 | $1.54M | Hold |
29,597
| – | – | 0.32% | 68 |
|
|
2013
Q4 | $1.57M | Hold |
29,597
| – | – | 0.33% | 67 |
|
|
2013
Q3 | $1.37M | Hold |
29,597
| – | – | 0.31% | 68 |
|
|
2013
Q2 | $1.32M | Buy |
+29,597
| New | +$1.28M | 0.32% | 66 |
|
Other funds holding BMY
Mogy Joel R Investment Counsel's BMY Position: Q2 2026 in Review
Mogy Joel R Investment Counsel held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 15,795 shares worth $910K. The position accounts for 0.05% of the portfolio, ranked #70.
Mogy Joel R Investment Counsel first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.4M in Q2 2022. 1,603 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Mogy Joel R Investment Counsel held 15,795 shares of Bristol-Myers Squibb worth $910K as of Q2 2026.
- Mogy Joel R Investment Counsel left its Bristol-Myers Squibb share count unchanged in Q2 2026.
- Bristol-Myers Squibb made up 0.05% of Mogy Joel R Investment Counsel's portfolio in Q2 2026, its #70 holding.
- Mogy Joel R Investment Counsel first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
- Mogy Joel R Investment Counsel's Bristol-Myers Squibb position peaked at $2.4M in Q2 2022.
- 1,603 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Mogy Joel R Investment Counsel's 13F filing for Q2 2026, filed 14 Jul 2026.